Physician profile
Rand Diab
NPI 1437105996
$1,494.26
in general payments reported to CMS, 2019-2025
18 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.18 · 2020: $29.59 · 2021: $133 · 2022: $281 · 2023: $256 · 2024: $251 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.48 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Alcon Vision LLC | $247.84 | 2022-2025 | Rocklatan, Tryptyr, Hydrus Microstent |
| Allergan, INC. | $145.83 | 2021-2022 | |
| Rxsight INC | $145.79 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Tarsus Pharmaceuticals, INC. | $115.33 | 2024-2025 | Xdemvy |
| Amgen INC. | $66.62 | 2025 | Tepezza |
| Dompe US, INC. | $54.83 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.04 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $45.43 | 2020-2022 | |
| Ocular Therapeutix, INC. | $41.01 | 2022 | |
| Horizon Therapeutics Plc | $40.70 | 2023 | Tepezza |
| Sight Sciences, INC. | $39.83 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $38.47 | 2023 | Vyzulta, Lotemax Sm, Envista Mx60 Iol |
| Sun Pharmaceutical Industries INC. | $37.16 | 2019-2020 | |
| Astellas Pharma US INC | $31.64 | 2024-2025 | Izervay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $24.07 | 2022 | |
| Shire North American Group INC | $23.05 | 2019 | |
| New World Medical,INC. | $1.14 | 2024 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rand Diab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.